What does Abbott Labs invest in?
Abbott Labs invests most often at Series B and Series D (100% of the rounds on record).
Abbott Labs highlights
- 01
2 rounds on record
- 02
Mostly Series B and Series D: 100% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2007
2 rounds
- Nov
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
EvalveBought by Abbott Labs$410MSept 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
Tendyne Holdings$250MJul 2015
Topera$250MOct 2014
ViroPharma$495MJun 2014
CFR Pharmaceuticals$2.9BMay 2014
OptiMedica$400MJul 2013
IDEV Technologies$310MJul 2013
Facet Biotech$450MMar 2010
Solvay Pharmaceuticals$6.6BSept 2009
Evalve$410MSept 2009
Visiogen$400MSept 2009
Ibis Biosciences$215MDec 2008
Spine NextUndisclosedOct 2004